Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Cystoid Fluid Collections in Retinoschisis
NCT06114537Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Jan 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide in X-linked retinoschisis (XLRS), sponsored by University of Amsterdam. Started Jan 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
X-linked retinoschisis (XLRS)
Beyond the preview
Go deeper on NCT06114537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06114537.